Clinical trials
STEMI clinical trials
Below are recruiting stemi clinical trials, each written for real people, not researchers. We’re tracking 74 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT06927791Recruiting
Using AI to spot heart problems earlier
This trial uses machine learning (a type of artificial intelligence) to help doctors diagnose acute heart or vessel conditions faster. It may lead to quicker treatment for patients with sudden heart problems.
BaselAges 18 years+ - NCT06951724Recruiting
New device to remove blood clots during a heart attack
This trial tests a special catheter designed to suction out blood clots from the heart's arteries during a heart attack. It may help restore blood flow and limit heart damage.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07055152Recruiting
Eye scan to understand heart attack risk in MINOCA patients
This study uses a special eye scan (OCTA) to look at tiny blood vessels in the eye and see if they can help predict outcomes for people who had a heart attack without blocked arteries (MINOCA). It compares these patients to others with typical heart attacks and healthy people.
Pisa, PisaAges Any age - NCT07026708Recruiting
Study of inflammation after heart attack
This study tracks inflammation in patients who had a heart attack and received a stent. It aims to understand inflammation levels after the event.
TiranaAges 18–85 - NCT06956560Recruiting
Heart Scar Imaging Study for Heart Attack and Failure Patients
This study uses a special imaging agent to see a protein called PDGFRß in the heart, which may help detect scarring (fibrosis) after a heart attack or in heart failure. It aims to improve how we understand and treat heart muscle damage.
UppsalaAges 40–70 - NCT06885619Recruiting
Predicting heart outcomes after a first heart attack with blood tests
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06795035Recruiting
Coronary microvascular testing after heart attack
This study tests a way to measure tiny blood vessels in the heart after a major heart attack (STEMI) using a special catheter with salt water. The goal is to see if this test helps doctors understand how well your heart is healing.
Cleveland, OhioAges 18 years+ - NCT06746233Recruiting
Balloon versus stent for heart attack treatment
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
Banja LukaAges 18 years+ - NCT06742125Recruiting
Drug balloon vs. stent for heart attack treatment
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
Hangzhou, ZhejiangAges 18 years+ - NCT06654453Recruiting
Blood clot removal during heart attack treatment
This trial tests whether removing the blood clot from the heart artery during a stent procedure can improve outcomes for people having a heart attack. If you fit the criteria, you may be randomly assigned to receive this extra clot-removal step or the standard stent procedure alone.
Changsha, HunanAges Any age - NCT06567249Recruiting
Cooling the heart during a heart attack procedure
This study tests whether cooling the heart with a cold liquid during a procedure (angioplasty) can help reduce damage after a heart attack. It may be an option for people who arrive at the hospital quickly after a heart attack.
TomskAges 18–90 - NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT06438315Recruiting
Observational Study of Oxygen Therapy After Heart Attack
This study is looking at how well a special oxygen treatment (SSO2 therapy) works for people who have had a heart attack and received a stent in the main front artery of the heart. It aims to see if the extra oxygen helps improve recovery.
Fountain Valley, CaliforniaAges 18–80 - NCT06384846Recruiting
AI predicts heart attacks using white blood cells
This study tests whether an artificial intelligence tool can accurately predict a heart attack (acute coronary syndrome) by looking at the properties of your white blood cells. If successful, it could help doctors diagnose heart attacks faster from a simple blood sample.
Graz, Styria / SteiermarkAges 18 years+ - NCT06353594Recruiting
Fewer stents vs usual stents for STEMI heart attack
This study compares using fewer stents versus the usual number of stents during emergency angioplasty for a severe heart attack (STEMI). It aims to see if a less-is-more approach is safe and effective.
Huelva, HuelvaAges 18 years+ - NCT06174753RecruitingPhase 3
Dapagliflozin for large heart attacks (STEMI)
This trial tests whether a diabetes drug called dapagliflozin can help people recover from a major heart attack (STEMI). You may qualify if you had a large heart attack within the last 12 hours and have not had a heart attack before.
Ottawa, OntarioAges 18 years+ - NCT06147986RecruitingPhase 2
Stem cell treatment after heart attack
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
TaichungAges 20–75 - NCT05892042Recruiting
Anticoagulant treatment for a heart clot after a heart attack
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
Changchun, JilinAges 18–80 - NCT05785897Recruiting
Stent without polymer plus aspirin-like therapy for heart attack
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
Geneva, Canton of GenevaAges 18 years+ - NCT05794022Recruiting
Study of heart attack patients getting heart MRI
This study follows people 18 and older who have had a specific type of heart attack (STEMI). It aims to better understand them using a heart MRI scan, which may help improve how these patients are evaluated and cared for.
Bron, RhoneAges 18 years+ - NCT05764057RecruitingPhase 3
Dapagliflozin to help the heart heal after a heart attack
This trial tests whether dapagliflozin (a diabetes medicine also used for heart protection) can reduce harmful heart “remodeling” after an acute heart attack. It may help your heart function and structure recover over the following 6 months.
ParisAges 18 years+ - NCT05491200RecruitingPhase 4
Test shorter blood-thinner use versus standard after heart attack
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
BonheidenAges Any age - NCT04939805Recruiting
Blood-cleaning treatment after first heart attack
This trial tests whether a blood-cleaning procedure called CRP apheresis, given after a first heart attack, can improve recovery when a heart-attack blood marker (CRP) is high. It’s aimed at people whose heart attack is treated quickly with a procedure to open blocked arteries, and who are well enough for heart MRI scans.
GrazAges 18–85
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stemi?
- Yes. Clin2 currently lists 74 recruiting stemi studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stemi trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stemi trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.